Background. Renal transplant recipients of older deceaseddonor kidneys have reduced allograft survival. However, the impact of donor-recipient age difference on live-donor kidney transplant outcomes, where donors are older than recipients, remains unclear. Methods. Using the Australia and New Zealand Dialysis and Transplant Registry, all primary live-donor kidney transplant recipients in Australia from 1991 to 2006 were studied. Donor-recipient age difference was divided into four categories (donor-recipient <−10, −10-20, 20-29 and ≥30 years). Outcome measures included serum creatinine, graft and patient survival. Results. In the adjusted model, donor-recipient age difference of ≥30 years showed a trend towards increased risk of graft failure compared with a difference of −10-20 years during the first year post-transplant only (hazard ratio= 2.11, 95% CI=1.00-4.47; P=0.05). However, in the multivariate competing risks Cox model, donor-recipient age difference was not associated with increased patient death, death-censored graft failure or serum creatinine at 5 or 10 years, nor was it associated with increased risk of acute rejection within the first 6 months. Conclusions. Recipients of kidney transplants donated by live donors who are significantly older than recipients have similar graft and patient survivals to recipients from organs of similar vintage. Thus, living kidney donors, who are up to 30 years older than their recipients, provide kidneys of excellent quality. These findings are of relevance when considering paired kidney donation programme because the chance of finding a suitable match should not be unnecessarily limited by unjustified restrictions on the perceived disadvantage of high donorrecipient age difference.
Introduction
A successful kidney transplant is the clinically preferred and most cost-effective treatment for many patients with end-stage kidney disease (ESKD). In many countries, static numbers of deceased organ donors and longer kidney transplant waiting lists have placed greater emphasis on living kidney donation as a means of meeting the demand for transplantation in patients with ESKD. Living kidney donation for transplantation is a routine and common procedure and is often the only means by which preemptive kidney transplantation is possible. With living donor kidneys, delayed graft function is unusual and long-term results from live related and unrelated donors show that they have equivalent graft survival and that they are superior to those from deceased donors, irrespective of tissue typing matches [1] [2] [3] . A recent systematic review describing transplant outcomes for recipients of living donor kidneys from 1980 to June 2008 suggests that recipients of kidneys from older living donors (>60 years of age) have poorer 5-year patient and graft survival than recipients of kidneys from younger donors [4] . These authors warned transplant professionals to counsel older living donors and their recipients in view of these findings. Three studies analysing outcomes of living donor transplantation as a function of donor age also accounted for confounding factors such as recipient age [5] [6] [7] , but the relationship between donor-recipient age difference and allograft outcomes was not specifically assessed.
In order to better understand the effect of donor-recipient age difference on live-donor kidney transplantation, we examined the 10-year outcomes of over 2364 adult livedonor renal transplant recipients in Australia.
Materials and methods
Using the Australia and New Zealand Dialysis and Transplant (ANZDATA) Registry, all primary live-donor renal transplant recipients in Australia from 1 April 1991 to 31 December 2006 were included in this study. Multiple-organ graft recipients and recipients with previous grafts were excluded from the study. Follow-up continued until 31 December 2007. The difference between donor and recipient age (recipient age subtracted from donor age) was divided into four categories (<−10, −10-20, 20-29 and ≥30 years). Recorded recipient characteristics included age, gender, race (categorized as indigenous or non-indigenous), the presence of diabetes and vascular disease (coronary artery disease and/or cerebrovascular disease and/or peripheral vascular disease) at commencement of renal replacement therapy, body mass index (BMI; categorized as <18.5, 18.5-<25, 25-<30 and ≥30 kg/m 2 ) at transplant, peak panel reactive antibody (PRA; categorized as 0-10, 11-50 and >50%) and time on dialysis (categorized as pre-emptive, 0-<1, 1-<3 and ≥3 years). Donor characteristics included age, gender and source (sibling, parent, other relative or unrelated). Transplant characteristics included number of human leukocyte antigen (HLA) mismatches, year of transplant and initial immunosuppression at transplant including calcineurin inhibitors (CNI; none, cyclosporine or tacrolimus), antimetabolites (none, mycophenolate mofetil/mycophenolic acid or azathioprine) and prednisolone. The primary clinical outcomes of this study were patient survival, graft survival, acute rejection within the first 6 months post-transplant (collected by ANZDATA from 1 April 1997) and serum creatinine concentrations at 1, 5 and 10 years post-transplant.
Statistics
Baseline characteristics were expressed as frequency (percentage) for categorical variables or mean (standard deviation) for normally distributed, continuous variables. Comparisons between donor-recipient age difference groups were carried out using chi-square test, Fisher's exact test or one-way ANOVA, as appropriate. Overall graft survival and patient survival were evaluated using Kaplan-Meier (KM) methods and Cox regression was used to obtain hazard ratios (HR) adjusted for confounding factors. Death-censored graft failure (DCGF) and death with functioning graft (DFG) were also examined as competing events using cumulative incidence and Cox regression was performed on an augmented dataset as described by Lunn and McNeil [8] to obtain cause-specific HR for each outcome. Acute rejection was analysed using binomial regression to estimate relative risks (RR). As serum creatinine was not normally distributed, this was modelled using a generalized linear model with a Gaussian distribution and a log-link to obtain differences in means. This transformation was superior than inverse transformation (1/creat) and it also performed regression on transformed data we cannot back-transform to obtain differences in means. The covariates included in multivariate models were donor age, donor gender, donor source, recipient age, recipient gender, race, BMI at transplant, diabetes, cardiovascular disease, peak PRA, time on dialysis, number of HLA mismatches, immunosuppression and transplant year.
Proportionality of hazards was assessed using methods based on Schoenfeld residuals and graphical methods. This assumption was not met for overall graft survival, so the follow-up period was divided into 0-1 and >1 year post-transplant to ensure proportional hazards for donor-recipient age difference groups. As outcomes showed reasonably linear relationships with donor age and number of HLA mismatches (when modelled as a fractional polynomial), these were analysed as continuous variables. Potential interactions between donor-recipient age difference groups and confounders were investigated, particularly interactions with recipient age and transplant year. A significant proportion (85%) of the sibling donors were HLA-identical transplants. The effect of donorrecipient age difference groups on clinical outcomes was also examined excluding grafts with zero HLA mismatches. Statistical analyses were performed using Stata/IC 10 (College Station, TX). P-values of <0.05 were considered statistically significant.
Results
Of the 2364 primary live-donor renal transplants recipients transplanted in Australia between 1 April 1991 and 31 December 2006, 1495 (63.2%) were recipients of kidneys from donors whose age was greater than the recipients' age. Characteristics of donors and recipients are shown in Table 1 . Donors of kidneys ≥20 years older than the recipient were almost exclusively (90%) parents, whereas siblings or unrelated (68% of which were spousal) donors were the major source of kidneys either younger or <20 years older than the recipient. Only 326 (13.8%) donors were older than 60 years of age. The age of the 882 recipients whose donors were ≥20 years older was <30 in 74% and 30-39 in 21% of cases. When the age difference was ≥30 years, 67% of donors were aged 50 or older. Recipients of kidneys from younger donors or donors <20 years older also had higher proportions of diabetes and cardiovascular disease (Table 1) . There was no evidence of interactions between donor-recipient age difference and recipient age or transplant year for any of the study outcomes. Excluding HLA-identical transplants did not significantly affect the conclusions.
Graft survival
A total of 445 (19%) grafts failed during the study period, either as a result of loss of function or patient death. Figure 1A shows the KM curve for graft survival by donorrecipient age difference. In the multivariate Cox regression model, donor-recipient age difference of ≥30 years showed a trend towards increased risk of graft failure compared with age difference of −10-20 years during the first year post-transplant, but this was not statistically significant at the 5% level (HR (0-1 year)=2.11, 95% CI=1.00-4.47; P=0.05) ( Table 2 ). Donor-recipient age difference was not associated with increased risk of graft failure after 1 year. Other covariates associated with increased graft failure were increasing donor age, indigenous race, BMI 25-<30 kg/m 2 , the presence of diabetes or cardiovascular disease and kidneys from unrelated donors. The use of cyclosporine was associated with reduced graft failure.
Death-censored graft survival and death with functioning graft
In total, 320 (14%) grafts failed for reasons other than patient death and 125 (5%) recipients died with a functioning graft. Figure 2 shows the cumulative incidences of DCGF and DFG by donor-recipient age difference categories, considering the two as competing events. The cumulative incidence of DCGF in the first 5 years differs posttransplant between age difference ≥30 years compared to <−10 years (P<0.005) and −10-20 years (P<0.005). The cumulative incidences of DFG significantly differ from 5 years post-transplant for age difference <−10 years compared to 20-29 years (P<0.05) and ≥30 years (P<0.005). In the multivariate competing risks Cox model, donorrecipient age difference did not significantly affect the cause-specific hazard for either DCGF or DFG (Table 2) . However, the power to detect differences for these endpoints individually was substantially less. Factors which did significantly increase the risk of DCGF included increasing donor age, non-Caucasian race, BMI 25-<30 kg/m 2 and the presence of cardiovascular disease, while the use of cyclosporine and tacrolimus were associated with decreasing hazard of DCGF. On the other hand, the presence of diabetes, cardiovascular disease, >1 year on dialysis prior to transplant, increasing number of HLA mismatches and peak PRA >50% were associated with increased DFG.
Patient survival
A total of 196 (8%) recipients died during the study period. Figure 1B shows the KM curve for patient survival by donor-recipient age difference. In the multivariate Cox regression model, donor-recipient age difference did not significantly affect the hazard of patient death ( Table 2 ). Covariates that were associated with increased patient death were the presence of diabetes or cardiovascular disease, increasing duration of dialysis prior to transplant, grafts from siblings or unrelated donors, peak PRA >50% and the use of azathioprine. 
Serum creatinine
Mean serum creatinine (in micromoles per litre) at 1, 5 and 10 years post-transplant by donor-recipient age difference is shown in Table 3 . In the multivariate model, donorrecipient age difference did not affect mean serum creatinine levels except at 1 year where there was a significant difference between the ≥30 and 20-29 years age difference groups (mean difference=−4.78, 95% CI=−7.60, −1.96).
Factors consistently associated with increased mean serum creatinine at 1 and 5 years post-transplant include recipient age, donor age, male recipients and BMI >30 kg/m 2 at transplant. Factors associated with increased mean serum creatinine at 10 years include male recipients and the presence of diabetes.
Acute rejection
For recipients transplanted from 1 April 1997, there were no significant differences in the risk of acute rejection within the first 6 months post-transplant between donor-recipient age difference groups ( Table 3 ). Factors that were associated with increased risk of acute rejection were increasing recipient age and increasing number of HLA mismatches. Sibling donors were associated with reduced risk of rejection. 
Discussion
This study demonstrates that recipients of kidney transplants donated by live donors who are significantly older than recipients have similar graft and patient survivals to recipients from organs of similar vintage. Although there was a trend for increased graft failure for donor-recipient age difference of ≥30 years compared with age difference of −10-20 years during the first year post-transplant, donor-recipient age difference was not associated with increased risk of graft failure after 1 year. Some other conventional covariates such as indigenous race, the presence of diabetes or cardiovascular disease were associated with increased graft failure. Donor covariates associated with increased graft failure were kidneys from unrelated donors and increasing donor age. One limitation of our study is that we looked at the relative and not absolute effect of donor age. In our cohort, 326 (13.8%) donors were aged 60 years or older. Data from cadaveric transplants indicate that advanced donor age is a risk factor for delayed graft function, rejection and reduced allograft survival [9] , in particular for recipients of kidneys from expanded criteria donors [10] . However, the negative impact of deceased-donor age on recipient outcomes does not seem to be apparent in livedonor kidney transplantation as shown by other studies [11] [12] [13] [14] [15] . Graft survival in recipients of kidneys from live donors >55 years of age [11] and from donors >60 years of age [12] [13] [14] [15] did not differ from those who received kidneys from younger donors. Nevertheless, this data from small, usually single-centre studies has been recently challenged by the systematic review by Iordanous et al. in which recipients of kidneys from donors >60 years of age were found to have poorer 5-year patient and graft survival than recipients from younger donors [4] . Some of the major drawbacks of this meta-analysis are the small numbers of donors in each of the 31 individual studies (23 studies had <65 recipients, 5 had more 200 recipients) and some assumptions on censoring of graft survival that had to be made where information was unavailable in the publications [4] .
In our analysis, a donor-recipient age difference <20 years was associated with poorer unadjusted recipient survival, but not with increased graft dysfunction or failure. This reflects confounding by recipient age (>70% of recipients of kidneys from donors <20 years their senior were over the age of 40 years, whereas recipient's age was <30 years in 74% of those who received a kidney from a donor >20 years older).
Older kidneys have lower functioning nephron mass with greater interstitial fibrosis and arteriolar hyalinosis demonstrated consistently in kidney donors as young as 40 years old [16] . In addition, older kidneys may have limited capacity to respond appropriately to physiological or pathological challenges leading to a greater decline in renal reserve [17] . It is plausible that older kidneys, when transplanted into younger recipients, may not be sufficient to cope with increases in physiological or metabolic demands leading to a greater reduction in renal function, a significant predictor of cardiovascular and all-cause mortality. Our results do not support these assumptions.
The analysis of post-transplant serum creatinine excluded failed grafts, which may have explained the lack of association between donor-recipient age difference and posttransplant graft function. Interestingly, Lim et al. showed that renal allograft recipients of parental donors had lower eGFR observed at 1 and 3 years post-transplantation [18] . However, in that study, a higher donor-recipient age difference was not associated with higher serum creatinine, even if the majority of donors were parental, when the transplanted kidney was >20 years the age of the recipient. Kumar reported a difference in creatinine clearance between recipients of older and younger donor kidneys at 1-and 5-year follow-up, although allograft survival and serum creatinine between groups did not differ [15] .
Renal allograft recipients of parental donors have been shown to be at greater risk of developing rejection by 6 months post-transplantation because these patients may be immunologically 'healthier', capable of eliciting a greater immune response to donor antigens [18] . Although recipient age was <30 years in 88% of the subjects who received a kidney from a donor >30 years their senior, there was no increased incidence of early rejection, suggesting that, with parental donors, factors other than recipient age may play a role for the described increase in acute early rejection.
The present findings are of major relevance for paired kidney donation (PKD), which is one option increasingly utilized to increase living donor rates to allow ABO incompatible or highly sensitized but otherwise willing and appropriate kidney donor-recipient pairs to exchange their kidneys [19] [20] [21] . In a prospective PKD, if an old donor-recipient pair is matched to a young donor-recipient pair, it could be argued that old living donors provide kidneys of inferior quality and, therefore, the young recipients may still be disadvantaged when trading with older living donors in a PKD [22] . In this situation, the younger recipient may not be willing to trade with an older donor because of the age-related decline in renal function beginning in the third decade of life [17, 23] . Refusal to an exchange could break the chain of potential matches identified after a match run and could limit the success of a PKD programme. The current data that renal transplant recipients of live related and unrelated donors have similar graft and patient survival even when the donor is up to 30 years older than the recipient does not support this view.
In a PKD programme, about half of the recipients are expected to be highly sensitized and thus it is relevant to understand whether a high donor-recipient age difference negatively affects outcomes in the presence of a high PRA. Although in our cohort of cross-matched negative recipients the number of highly sensitized subjects with a peak PRA of >50% was small (∼5%), the degree of sensitization was not significantly associated with decreased graft or patient survival in the multivariate model. Thus, it can be argued that for a young, highly sensitized patient with a low match probability, the putative disadvantage of receiving an older kidney is likely offset by avoiding the disadvantages of remaining or commencing dialysis if no suitable donor is found [24] .
Conclusion
In conclusion, these findings demonstrate that renal transplant recipients of live related and unrelated donors have similar graft and patient survival even when the donor is up to 30 years older than the recipient. Expanding the live kidney donor pool with a PKD programme should not be limited by unjustified restrictions on the perceived disadvantage of high donor-recipient age difference because this could reduce the chance of finding a suitable match, particularly when the size of the donor-recipient pool is small, unnecessarily increasing the waiting time on dialysis, which is a strong determinant of negative post-transplant graft and patient survival.
